Facebook shares dipped roughly seven percent on Monday and lost $35 billion to its market cap following reports that it had dismissed a security breach that permitted a data mining company access to information of over 50 million Facebook users.

Cancer treatment is a complicated matter for companies due to the varying types of the disease. When a life science company conducts research or seeks to develop a product for this market, it is more likely than not that they set on a very specific type of cancer to fight.

Apellis Pharmaceuticals (Nasdaq:APLS), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, today announced its fourth quarter and full year 2017 financial results and business highlights.

As quoted in the press release:
“In 2017 we made significant progress across our clinical programs and successfully completed our initial public offering. This